VBI Vaccines Inc/BC Increase Decrease In Operating Lease Liability
VBI Vaccines Inc/BC reported Increase Decrease In Operating Lease Liability of -$400.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2024-05-15
- VBI Vaccines Inc/BC increase decrease in operating lease liability for the quarter ending 2024-03-31 was -$400.00K.
- VBI Vaccines Inc/BC increase decrease in operating lease liability for the quarter ending 2023-12-31 was -$435.00K.
- VBI Vaccines Inc/BC increase decrease in operating lease liability for the quarter ending 2023-09-30 was -$315.00K.
- VBI Vaccines Inc/BC increase decrease in operating lease liability for the quarter ending 2023-06-30 was -$322.00K, a 131.72% decline year-over-year.
- VBI Vaccines Inc/BC increase decrease in operating lease liability for fiscal 2023 was -$1.41M.
- VBI Vaccines Inc/BC increase decrease in operating lease liability for fiscal 2022 was -$1.35M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$400.00K 10-Q · filed 2024-05-15 | -$835.00K derived: sum of 2 quarters · filed 2024-05-15 | -$1.15M derived: sum of 3 quarters · filed 2024-05-15 | -$1.47M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | -$435.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$750.00K derived: sum of 2 quarters · filed 2024-04-16 | -$1.07M derived: sum of 3 quarters · filed 2024-04-16 | -$1.41M 10-K · filed 2024-04-16 |
| 2023-09-30 | -$315.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$637.00K derived: sum of 2 quarters · filed 2023-11-14 | -$971.00K 10-Q · filed 2023-11-14 | -$1.32M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-06-30 | -$322.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$656.00K 10-Q · filed 2023-08-14 | -$1.00M derived: sum of 3 quarters · filed 2024-05-15 | -$2.68M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-03-31 | -$334.00K 10-Q · filed 2024-05-15 | -$680.00K derived: sum of 2 quarters · filed 2024-05-15 | -$2.35M derived: sum of 3 quarters · filed 2024-05-15 | -$1.34M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$2.02M derived: sum of 2 quarters · filed 2024-04-16 | -$1.01M derived: sum of 3 quarters · filed 2024-04-16 | -$1.35M 10-K · filed 2024-04-16 |
| 2022-09-30 | -$1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$660.00K derived: sum of 2 quarters · filed 2023-11-14 | -$1.00M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $674.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$341.00K 10-Q · filed 2023-05-15 |